News Releases

DOT announces updates to drug-testing program

  • Jan 31, 2018

The Department of Transportation (DOT) announced it is amending its drug-testing program regulations as of Jan. 1, 2018.

The following opioids have been added to the DOT drug-testing panel: hydrocodone, hydromorphone, oxymorphone, and oxycodone. Some common names for these new opioids include OxyContin, Opana, Percodan, Percocet, Vicodin, Lortab, Norco and Dilaudid. The panel already includes cocaine, marijuana, phencyclidine, amphetamine/methamphetamine, morphine and codeine.

The regulation change also removes the requirement for employers or TPAs to submit blind specimens on an annual basis. You can continue to use the existing Chain of Custody (COC) forms until further notice.

Sanford OccMed is prepared for the upcoming changes. In addition, our non-DOT look-alike send in full drug panels will be adjusted to match the new DOT urine drug panel. At the moment, there is no DOT look-alike quick cup.

Please review your company drug-testing policy to ensure it is updated with these additional drugs. Further information on pricing changes will soon be available.

For more information, call Sanford OccMed drug-testing division at (888) 600-2378.